InvestorsHub Logo
Followers 52
Posts 2087
Boards Moderated 0
Alias Born 03/30/2016

Re: ap17 post# 47074

Tuesday, 04/02/2019 6:40:53 PM

Tuesday, April 02, 2019 6:40:53 PM

Post# of 83039
Other CBD producers include CV Sciences (OTC: CVSI), and we own some shares (from a low 2018 price point) in case something happens. We have been disappointed with management. Retailers complain about poor customer service; investors complain management ignores them. Quarterly sales growth has fallen off a cliff, down to just 4% in Q4. Its NASDAQ application has sat DOA now for nine months, which means there has to be something wrong? Plus, management still bizarrely insists in dividing the company, confusing investors and wasting half the presentation—as a pharmaceutical developer. It has no patent, which the U.S. Patent Office keeps denying. To us, the drug dream is presently "worthless" and only heavily promoted as some sort of ego trip.

-----


ouch. sounds familiar

where have i heard this before